Moreover, the chemoimmunotherapy regimen consisted of nab-paclitaxel plus gemcitabine combined with WT1-DC vaccination regulated TME and facilitated conversion surgery for advanced pancreatic cancer patients (54). The gene discussed is WT1; the disease is pancreatic neoplasm.